Sound Pharmaceuticals Obtains $3,800,000 New Financing Round

Feed Type
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=41fc3494-12d0-4e35-82c2-955d96e1c8e9
Date
9/19/2016
Company Name
Sound Pharmaceuticals
Mailing Address
4010 Stone Way N Seattle, WA 98103 USA
Company Description
Sound Pharmaceuticals (SPI) is a privately held biopharmaceutical company in Seattle, WA. Our goal is to develop prescription drugs that will enable doctors and patients to prevent and treat hearing loss, a disease that affects over 30 to 40 million Americans.
Website
http://www.soundpharmaceuticals.com
Transaction Type
Debt
Transaction Amount
$3,800,000
Transaction Round
Undisclosed
Proceeds Purposes
Proceeds purposes were not disclosed. 4 investors participated in the offering. The amount may include options, warrants or other securities. Contact technology company for investment details, if applicable. Not an offer or solicitation for the sale of securities or debt. SEC regulatory filing.
M&A Terms
Venture Investor
Undisclosed